The U.S. Supreme Court on Friday issued an order staying (stopping) a lower court ruling that blocked the FDA’s approval of the abortion pill.

The court granted a request by the Biden administration and Danco Laboratories – an abortion pill manufacturer – to put U.S. District Judge Matthew Kacsmaryk’s April 7, 2023, order blocking the abortion pill on ice.

Two justices – Justices Thomas and Alito – said they would deny the request for a stay, while Justice Alito also penned a 4-page dissent from the court’s decision.

Now, it’s important to note that the Supreme Court’s judgement does not signal an end to litigation in this case.

Rather, the court’s ruling is only the end of the beginning in this case.

The Supreme Court’s ruling has only decided not to keep in place a preliminary injunction issued by U.S. District Judge Matthew Kacsmaryk, who ruled that the FDA could not maintain its approval of the abortion pill while the merits of the case are being deliberated.

After Judge Kacsmaryk’s order, the U.S. Court of Appeals for the Fifth Circuit partially reversed his decision, but placed several limits on the use of the abortion pill while the lawsuit proceeds. The Supreme Court’s ruling overrides both of these decisions.

Now, the lawsuit goes back down to the appeals court, where lawyers from Alliance Defending Freedom (ADF) and the FDA will present their arguments on the merits in the case. ADF alleges that the FDA violated the law in approving the abortion pill in 2000. In the meantime, mifepristone will continue to remain on the market.

In a statement after the ruling, Alliance Defending Freedom Senior Counsel Erik Baptist said this about the ruling:

As is common practice, the Supreme Court has decided to maintain the status quo that existed prior to our lawsuit while our challenge to the FDA’s illegal approval of chemical abortion drugs and its removal of critical safeguards for those drugs moves forward. Our case seeking to put women’s health above politics continues on an expedited basis in the lower courts.

The FDA must answer for the damage it has caused to the health of countless women and girls and the rule of law by failing to study how dangerous the chemical abortion drug regimen is and unlawfully removing every meaningful safeguard, even allowing for mail-order abortions. We look forward to a final outcome in this case that will hold the FDA accountable.

The Daily Citizen will keep you apprised of important developments in this case.

The case is Danco Laboratories v. Alliance for Hippocratic Medicine.

Some women, after taking the first abortion pill (mifepristone) come to regret their decision. Thankfully, there is a way to reverse the pill’s effects if prompt action is taken.

To learn more about the abortion pill reversal protocol, visit or call 1-877-558-0333 to be connected with a medical professional who can guide callers through the process of reversing the pill’s effects.

Additionally, if you’re struggling and need a listening ear, Focus on the Family offers a free, one-time counseling consultation with a licensed or pastoral counselor. To request a counseling consultation, call 1-855-771-HELP (4357) or fill out our Counseling Consultation Request Form.

The case is Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration.

Related articles and resources:

My Choice Network

Focus on the Family Pro-Life